Michael J. Brooks, President at Edesa Biotech, Inc. (EDSA), bought 1,250 shares at $2.90 ($4K) on 2022-03-08, disclosed to the SEC on 2022-03-09.
Open-market purchase of $4k EDSA by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| EDSA | BUY | 2022-06-21 | $5K | — | Filing → |
| EDSA | BUY | 2022-05-26 | $6K | — | Filing → |
| EDSA | BUY | 2022-03-15 | $3K | — | Filing → |